Barsottini Ogp , Ferraz HB, Seviliano MM, Barbieri A.: Brain SPECT imaging in Sydenham's chorea . Braz J Med Biol Res2002;35:431—436.
5.
Goldman S., Amrom D., Szliwowski HB, et al: Reversible striatal hypermetabolism in a case of Sydenham's chorea. Mov Disord1993; 8:355—358.
6.
Weindl A., Kuwert T., Leenders KL, et al: Increased striatal glucose consumption in Sydenham's chorea . Mov Disord1993;8:437—444.
7.
Hill A., Herkes GK, Roche P.: SPECT and MRI findings in Sydenham's chorea. J Neurol Neurosurg Psychiatry1994;57:763.
8.
Heye N., Jergas M., Hotzinger H., et al: Sydenham chorea: Clinical, EEG, MRI and SPECT findings in the early stage of the disease. J Neurol1993;240: 121—123.
9.
Demiroren K. , Tastekin G., Oran B.: Diagnostic role of Tc hexamethylpropyleneamine oxime brain single photon emission computed tomography in Sydenham's chorea . Pediatr Int2004;46:450—455.
10.
Brooks DJ, Ibanez V., Sawle GV, et al: Differing patterns of striatal 18 F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ann Neurol1990;28:547—555.
11.
Snow BJ, Bhatt M., Martin Wrw, et al: The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography. J Neurol Neurosurg Psychiatry1991;54:12—17.
12.
Deckel AW, Weiner R., Szigeti D.,et al:Altered patterns of regional cerebral blood flow in patients with Huntington's disease: A SPECT study during rest and cognitive or motor activation . J Nucl Med2000;41:773—780.
13.
Visser JE, Bar PR, Jinnah HALesch-Nyhan disease and the basal ganglia. Brain Res Brain Res Rev2000;32:449—475.
14.
Martin Wrw, Hayden MR, Suchowersky O., et al: Striatal metabolism in Huntington's disease and in benign hereditary chorea. Ann Neurol1984;16:126.
15.
Cardoso F.: Infectious and transmissible movement disorders, in Jankovic J, Tolosa E (eds): Parkinson's Disease and Movement Disorders, 3rd ed. Baltimore, Williams Wilkins , 1998, 945—965.